This study explores how a new medicine, **eloralintide**, helps people with type 2 diabetes and who are either overweight or obese, to lose weight safely. Type 2 diabetes is a condition where the body doesn't use insulin properly, leading to high blood sugar levels. The study compares eloralintide to a placebo (a substance with no active medicine) over about 75 weeks, which is a little over a year. To join the study, you must have type 2 diabetes, a BMI (Body Mass Index) of 27 or more, and a stable weight for at least 90 days. People who have had certain surgeries, procedures, or specific medicines for diabetes or weight loss recently, or who have serious heart conditions, can't participate.
- Duration: The study lasts for about 75 weeks.
- Eligibility: Must have type 2 diabetes and a BMI of 27 or higher.
- Exclusions: Recent heart problems or certain diabetes treatments disqualify participation.
How understandable was the trial content above?
Hard to understand
Easy to understand